Tumor necrosis factor-driven cell death in donor organ as a barrier to immunological tolerance

Rosalind L Ang1, Adrian T Ting

  • 1Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Abstract

Insights

Regulated cell death triggered by tumor necrosis factor-alpha (TNF) may drive organ rejection. Disrupting cell death checkpoints increases sensitivity to TNF, potentially leading to allograft rejection and informing therapeutic strategies.

Area of Science:

  • Immunology
  • Cell Biology
  • Transplantation Science

Background:

  • Regulated cell death (RCD) mechanisms, including apoptosis and necroptosis, are implicated in organ rejection.
  • Tumor necrosis factor-alpha (TNF) is a key cytokine that triggers RCD and inflammation via NFκB and MAPK signaling pathways.
  • While cells typically survive TNF exposure due to death checkpoints, disrupted checkpoints can lead to TNF-induced cell death.

Purpose of the Study:

  • To explore the role of TNF-induced cell death in organ rejection.
  • To investigate how TNF-induced cell death contributes to inflammation and immune responses in transplantation.
  • To propose that a cell's susceptibility to TNF-driven death influences allograft survival.

Main Methods:

  • Review of emerging data from animal models on TNF-induced inflammatory cell death.
  • Analysis of the role of cell death checkpoints in determining cellular response to TNF.
  • Consideration of genetic, epigenetic, and posttranslational regulation of death checkpoints.

Main Results:

  • TNF-induced cell death can be inflammatory, suggesting a role for cellular demise in regulating immunity.
  • Ischemia reperfusion (IR) injury in transplantation may involve TNF-mediated cellular injury or death, impacting organ survival.
  • Reduced function of cell death checkpoints increases sensitivity to TNF, potentially leading to cell death.

Conclusions:

  • A cell's propensity to undergo TNF-driven death may be a critical factor in allograft rejection.
  • Control of death checkpoint regulators in donor tissues is crucial for graft survival.
  • Therapeutic strategies targeting donor cell death could prevent organ rejection.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.6K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
724
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.9K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
16.8K
Factors Affecting Drug Distribution: Organ Perfusion Rate01:15

Factors Affecting Drug Distribution: Organ Perfusion Rate

Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
604